Zdrowie i gospodarka · 14/11/2017
FDA Classifies Prostatic Artery Embolization Device into Class II with Special Controls
The FDA has classified the prostatic artery embolization device into Class II with special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.
Source: Federal Register — Food and Drug AdministrationOpen original release →